丙酸氟替卡松联合斯奇康治疗儿童哮喘对肺功能的影响  

Observation of effect on lung function in childhood asthma treated with fluticasone propionate and BCG-PSN

作　　者：龚财惠[1] 符州[1] 戴继宏[1] 石田田[1] 王成秀[1] 

机构地区：[1]重庆医科大学附属儿童医院,重庆400014

出　　处：《儿科药学杂志》2003年第6期26-27,共2页Journal of Pediatric Pharmacy

摘　　要：目的:观察哮喘患儿吸入丙酸氟替卡松(辅舒酮)和注射斯奇康治疗后对肺功能的影响程度。方法:应用MasterScope儿童肺功能仪对儿童哮喘进行用药前后肺功能指标测定。结果:在受检20例患儿中,治疗前后其肺功能指标除FVC、FEV1外,PEF、FEF25、FEF50、FEF75均有显著性差异(P<0.05)。结论:丙酸氟替卡松和斯奇康联合用于儿童哮喘的治疗及预防,对缓解症状和改善肺功能均能收到良好效果。Objective: To observe the degree of effect on lung function in childhood asthmatics treated with fluticasone propionate inhalation and BCG-PSN injection. Methods: To test lung function indicators with MasterScope spirometer before and after administration. Results: There exists significsnt difference betreen PEF, FEF25, FEF50 and FEF75 except FVC and FEV1.0 before and after administration in 20 patients. Conclusion: Good result can be attained in symptoms and lung function in asthmatics treated with fluticasone propionate and BCG-PSN.

关 键 词：丙酸氟替卡松 联合用药 斯奇康 药物治疗 儿童 哮喘 肺功能 

分 类 号：R725.622.5[医药卫生—儿科]